This company provides at-home vaginal microbiome testing using CLIA-certified metagenomic sequencing to analyze over 700 bacteria and fungi. Results are reviewed by clinicians who offer personalized insights and custom care plans, including prescription treatment options when eligible. The platform supports proactive vaginal health management related to symptoms, fertility, and menopause.
Funding
$14M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
LLFounders
Product
Problem
Many individuals with vaginas experience recurring or persistent vaginal health issues, such as infections and imbalances, that are difficult to diagnose and treat effectively with standard clinical methods. Traditional testing often provides incomplete information about the vaginal microbiome, leading to inadequate or ineffective treatments. The lack of comprehensive understanding of the vaginal microbiome contributes to delayed diagnoses and prolonged discomfort for many individuals.
Solution
Evvy offers an at-home vaginal microbiome test that utilizes metagenomic sequencing to provide a comprehensive analysis of the bacteria, fungi, and other microorganisms present in the vaginal environment. This advanced testing method identifies the specific composition of the vaginal microbiome, offering insights into the root causes of symptoms related to infections, fertility, and overall vaginal health. Based on the test results, Evvy provides personalized care plans, including evidence-based recommendations and prescription treatment options, tailored to address individual needs and restore microbial balance. The platform also offers ongoing tracking and monitoring to assess the impact of treatments and lifestyle changes on the vaginal microbiome.
Target Audience
Evvy primarily targets women and individuals with vaginas experiencing vaginal health issues, such as recurrent infections, fertility challenges, or general imbalances, who are seeking comprehensive insights and personalized solutions.
Features
- At-home vaginal microbiome test using CLIA-certified metagenomic sequencing for comprehensive analysis.
- Identification of all bacteria, fungi, and other microorganisms in the vaginal microbiome.
- Personalized care plans with clear next steps based on individual test results.
- Prescription treatment programs developed by Evvy-affiliated providers (where eligible).
- Access to science-backed education, community support, and 1:1 coaching.
- Proactive tracking of the vaginal microbiome to monitor the impact of treatments and behaviors.
- Option to add an STI + PCR panel for comprehensive screening.